| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb125c4e9cdd343e06536f2d4b22f069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4fedd3001b970d69d50746059aedfdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de10d056699413726642328e08ffb187 |
| publicationDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008208074-A |
| titleOfInvention |
Anticancer agent containing pyrazine derivative as active ingredient |
| abstract |
A pyrazine derivative having a therapeutic effect on cancer is provided. An anticancer agent comprising, as an active ingredient, formula I (wherein A represents a specific heterocyclic group and X represents a nitrogen or carbon atom). [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015341913-B2 |
| priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |